Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas (Q43757715)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas |
scientific article |
Statements
1 reference
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas (English)
1 reference
Tahamtan Ahmadi
1 reference
Elise A Chong
1 reference
Amanda Gordon
1 reference
Nicole A Aqui
1 reference
Sunita D Nasta
1 reference
Jakub Svoboda
1 reference
Anthony R Mato
1 reference
Stephen J Schuster
1 reference
7 October 2013
1 reference
1 reference
120
1 reference
2
1 reference
222-228
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference